Just one year since its inception, the Clinical Trials Network of Tennessee (CTN2) has secured contracts to work with nine clinical sites across the state and has enrolled over 20 Tennesseans as patients in their trials. The innovative clinical trials network aims to provide new therapeutics and medical devices with the overarching goal of improving… Read More
Newly published results from a multinational study co-authored by Kenneth Ataga, MD, director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) and the Memphis Consortium for Sickle Cell Disease and Non-Malignant Hematology Research, indicated voxelotor, a novel experimental drug for sickle cell disease, reduced anemia and boosted… Read More
Message from the Chancellor: I am pleased to report the University of Tennessee Board of Trustees approved the UTHSC budget at their meeting this past Friday, June 21. As I articulated in our recent Town Hall, “It is a good, but challenging budget year.” Key points: Tuition was held to increases of only $200 per… Read More